Market Overview

Benzinga's Top Initiations

Related INFI
3 Small-Cap Biotechs That Institutions Are Loving
UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals On Data Upside Driver
Related CVD
Covance Expands in Market Access - Analyst Blog
Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog

Analysts at William Blair initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ: INFI) with a “market perform” rating. The target price for Infinity Pharmaceuticals is set to $21. Infinity's shares closed at $19.20 yesterday.

Credit Suisse initiated coverage on shares of Covance (NYSE: CVD) with an “outperform” rating. The target price for Covance is set to $101. Covance's shares closed at $85.02 yesterday.

Jefferies initiated coverage on shares of Church & Dwight Co (NYSE: CHD) with a “buy” rating. The target price for Church & Dwight is set to $72. Church & Dwight's stock closed at $61.78 yesterday.

Analysts at Morgan Stanley initiated coverage on shares of Booz Allen Hamilton Holding (NYSE: BAH) with an “equal-weight” rating. The target price for Booz Allen Hamilton is set to $21. Booz Allen Hamilton's shares closed at $19.38 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (CHD + BAH)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters